Oncogenesis - Table of Contents alert Volume 7, July 2018

TABLE OF CONTENTS Volume 7 (July 2018) In this issue Article Article A dual role of miR-22 modulated by RelA/p65 in resensitizing fulvestrant-resistant breast cancer cells to fulvestrant by targeting FOXP1 and HDAC4 and constitutive acetylation of p53 at Lys382 Bo Wang, Dongping Li, Jody Filkowski, Rocio Rodriguez-Juarez, Quinn Storozynsky et al. Oncogenesis 2018 7: 10.1038/s41389-018-0063-5 Abstract | Full Text Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer Francesca De Nicola, Frauke Goeman, Matteo Pallocca, Francesca Sperati, Laura Pizzuti et al. Oncogenesis 2018 7: 10.1038/s41389-018-0066-2 Abstract | Full Text p38 MAPK pathway and its interaction with TRF2 in cisplatin induced chemotherapeutic response in head and neck cancer Shomereeta Roy, Souvick Roy, Madhabananda Kar, Shweta Thakur, Yusuf Akhter et al. Oncogenesis 2018 7: 10.1038/s41389-018-0062-6 Abstract | Full Text FOXC1 plays a crucial role in the growth of pancreatic cancer Ramadevi Subramani, Fernando A. Camacho, Carly Ivy Levin, Kristina Flores, Alexa Clift et al. Oncogenesis 2018 7: 10.1038/s41389-018-0061-7 Abstract | Full Text Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignancies Olga Ostrovsky, Ania Hava Grushchenko-Polaq, Katia Beider, Margarita Mayorov, Jonathan Canaani et al. Oncogenesis 2018 7: 10.1038/s41389-018-0060-8 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogenesis. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.